0001179110-17-015232.txt : 20171211 0001179110-17-015232.hdr.sgml : 20171211 20171211182330 ACCESSION NUMBER: 0001179110-17-015232 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171207 FILED AS OF DATE: 20171211 DATE AS OF CHANGE: 20171211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ESHELMAN FREDRIC N CENTRAL INDEX KEY: 0001033409 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31191 FILM NUMBER: 171250592 MAIL ADDRESS: STREET 1: PPD INC STREET 2: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICINES CO /DE CENTRAL INDEX KEY: 0001113481 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043324394 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-290-6000 MAIL ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: MEDICINES CO/ MA DATE OF NAME CHANGE: 20000504 4 1 edgar.xml FORM 4 - X0306 4 2017-12-07 0 0001113481 MEDICINES CO /DE MDCO 0001033409 ESHELMAN FREDRIC N 8 SYLVAN WAY PARSIPPANY NJ 07054 1 1 0 0 Executive Chairman Common Stock 2017-12-07 4 P 0 100000 26.46 A 1028383 D Common Stock 2017-12-08 4 P 0 100000 26.65 A 1128383 D Common Stock 944537 I See footnote The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $26.24 to $26.60 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $26.40 to $26.81 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. These shares of the issuer's common stock are owned by Eshelman Ventures, LLC, an entity wholly owned by the reporting person. /s/ Stephen M. Rodin, Attorney-in-Fact for Fredric N. Eshelman 2017-12-11